68 related articles for article (PubMed ID: 12429973)
1. Tetrandrine-induced cell cycle arrest and apoptosis in A549 human lung carcinoma cells.
Lee JH; Kang GH; Kim KC; Kim KM; Park DI; Choi BT; Kang HS; Lee YT; Choi YH
Int J Oncol; 2002 Dec; 21(6):1239-44. PubMed ID: 12429973
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of cyclin D1 expression and induction of apoptosis by inostamycin in small cell lung carcinoma cells.
Imoto M; Tanabe K; Simizu S; Tashiro E; Takada M; Umezawa K
Jpn J Cancer Res; 1998 Mar; 89(3):315-22. PubMed ID: 9600126
[TBL] [Abstract][Full Text] [Related]
3. Growth inhibition and induction of G1 phase cell cycle arrest in human lung cancer cells by a phenylbutenoid dimer isolated from Zingiber cassumunar.
Lee JW; Min HY; Han AR; Chung HJ; Park EJ; Park HJ; Hong JY; Seo EK; Lee SK
Biol Pharm Bull; 2007 Aug; 30(8):1561-4. PubMed ID: 17666821
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of tetrandrine and its therapeutic use in digestive diseases.
Li DG; Wang ZR; Lu HM
World J Gastroenterol; 2001 Oct; 7(5):627-9. PubMed ID: 11819843
[No Abstract] [Full Text] [Related]
5. Erratum to: Tetrandrine Represses Inflammation and Attenuates Osteoarthritis by Selective Inhibition of COX-2.
Gao P; Rao ZW; Li M; Sun XY; Gao QY; Shang TZ; Chen C; Zhang CL
Curr Med Sci; 2023 Aug; 43(4):845-846. PubMed ID: 37535250
[No Abstract] [Full Text] [Related]
6. The impact of cycleanine in cancer research: a computational study.
Nwaefulu ON; Al-Shar'i NA; Owolabi JO; Sagineedu SR; Woei LC; Wai LK; Islam MK; Jayanthi S; Stanslas J
J Mol Model; 2022 Oct; 28(11):340. PubMed ID: 36194315
[TBL] [Abstract][Full Text] [Related]
7. Exploring the recent trends in perturbing the cellular signaling pathways in cancer by natural products.
Rahman MM; Sarker MT; Alam Tumpa MA; Yamin M; Islam T; Park MN; Islam MR; Rauf A; Sharma R; Cavalu S; Kim B
Front Pharmacol; 2022; 13():950109. PubMed ID: 36160435
[TBL] [Abstract][Full Text] [Related]
8. Progress on structural modification of Tetrandrine with wide range of pharmacological activities.
Mo L; Zhang F; Chen F; Xia L; Huang Y; Mo Y; Zhang L; Huang D; He S; Deng J; Hao E; Du Z
Front Pharmacol; 2022; 13():978600. PubMed ID: 36052124
[TBL] [Abstract][Full Text] [Related]
9. Growth-Suppressive and Apoptosis-Inducing Effects of Tetrandrine in SW872 Human Malignant Liposarcoma Cells via Activation of Caspase-9, Down-Regulation of XIAP and STAT-3, and ER Stress.
Samsuzzaman M; Jang BC
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740967
[TBL] [Abstract][Full Text] [Related]
10. Combination Nanotherapeutics for Dry Eye Disease Treatment in a Rabbit Model.
Huang L; Gao H; Wang Z; Zhong Y; Hao L; Du Z
Int J Nanomedicine; 2021; 16():3613-3631. PubMed ID: 34079253
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological evaluation and toxicity of novel tetrandrine analogues.
Schütz R; Müller M; Geisslinger F; Vollmar A; Bartel K; Bracher F
Eur J Med Chem; 2020 Dec; 207():112810. PubMed ID: 32942071
[TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis of Novel Tetrandrine-14-l-Amino Acid and Tetrandrine-14-l-Amino Acid-Urea Derivatives as Potential Anti-Cancer Agents.
Hu SC; Yang J; Chen C; Song JR; Pan WD
Molecules; 2020 Apr; 25(7):. PubMed ID: 32283819
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and bioactivity investigation of tetrandrine derivatives as potential anti-cancer agents.
Song J; Lan J; Chen C; Hu S; Song J; Liu W; Zeng X; Lou H; Ben-David Y; Pan W
Medchemcomm; 2018 Jul; 9(7):1131-1141. PubMed ID: 30109000
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effects of tetrandrine combined with ionizing radiation on a murine colorectal carcinoma‑bearing mouse model.
Lin WC; Wang WH; Lin YH; Leu JD; Cheng SY; Chen YJ; Hwang JJ
Oncol Rep; 2018 Sep; 40(3):1390-1400. PubMed ID: 30015952
[TBL] [Abstract][Full Text] [Related]
15. Tetrandrine suppresses adhesion, migration and invasion of human colon cancer SW620 cells via inhibition of nuclear factor-κB, matrix metalloproteinase-2 and matrix metalloproteinase-9 signaling pathways.
Juan TK; Liu KC; Kuo CL; Yang MD; Chu YL; Yang JL; Wu PP; Huang YP; Lai KC; Chung JG
Oncol Lett; 2018 May; 15(5):7716-7724. PubMed ID: 29731901
[TBL] [Abstract][Full Text] [Related]
16. c-MYC and reactive oxygen species play roles in tetrandrine-induced leukemia differentiation.
Wu G; Liu T; Li H; Li Y; Li D; Li W
Cell Death Dis; 2018 May; 9(5):473. PubMed ID: 29700286
[TBL] [Abstract][Full Text] [Related]
17. Tetrandrine (TET) Induces Death Receptors Apo Trail R1 (DR4) and Apo Trail R2 (DR5) and Sensitizes Prostate Cancer Cells to TRAIL-Induced Apoptosis.
Shishodia G; Koul S; Dong Q; Koul HK
Mol Cancer Ther; 2018 Jun; 17(6):1217-1228. PubMed ID: 29549167
[TBL] [Abstract][Full Text] [Related]
18. Natural Compounds as Modulators of Cell Cycle Arrest: Application for Anticancer Chemotherapies.
Bailon-Moscoso N; Cevallos-Solorzano G; Romero-Benavides JC; Orellana MI
Curr Genomics; 2017 Apr; 18(2):106-131. PubMed ID: 28367072
[TBL] [Abstract][Full Text] [Related]
19. The effect of tetrandrine combined with cisplatin on proliferation and apoptosis of A549/DDP cells and A549 cells.
Ye LY; Hu S; Xu HE; Xu RR; Kong H; Zeng XN; Xie WP; Wang H
Cancer Cell Int; 2017; 17():40. PubMed ID: 28360820
[TBL] [Abstract][Full Text] [Related]
20. Tetrandrine Exerts a Radiosensitization Effect on Human Glioma through Inhibiting Proliferation by Attenuating ERK Phosphorylation.
Ma JW; Zhang Y; Ye JC; Li R; Wen YL; Huang JX; Zhong XY
Biomol Ther (Seoul); 2017 Mar; 25(2):186-193. PubMed ID: 27829269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
